6-phenylhexyl isothiocyanate has been researched along with sulindac in 1 studies
| Studies (6-phenylhexyl isothiocyanate) | Trials (6-phenylhexyl isothiocyanate) | Recent Studies (post-2010) (6-phenylhexyl isothiocyanate) | Studies (sulindac) | Trials (sulindac) | Recent Studies (post-2010) (sulindac) |
|---|---|---|---|---|---|
| 39 | 0 | 6 | 1,462 | 202 | 305 |
| Protein | Taxonomy | 6-phenylhexyl isothiocyanate (IC50) | sulindac (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.69 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 2.69 | |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 0.293 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 8.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelloff, GJ; Rao, CV; Reddy, BS; Samaha, HS; Steele, V | 1 |
1 other study(ies) available for 6-phenylhexyl isothiocyanate and sulindac
| Article | Year |
|---|---|
Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Biomarkers, Tumor; Caffeic Acids; Carcinogens; Colonic Neoplasms; Curcumin; Isothiocyanates; Male; Rats; Rats, Inbred F344; Sulindac | 1997 |